GlassScriptPhysician profile
Mary Kay Klockmann
NPI 1003840174
$6,343.65
in general payments reported to CMS, 2019-2025
32 companies · $2,065 in 2025
The $2,065 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $648 · 2022: $831 · 2023: $941 · 2024: $1,859 · 2025: $2,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,765 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,764.73 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,434.77 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $1,422.32 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $754.69 | 2021-2025 | Zepbound, Mounjaro, Kisunla |
| Amgen INC. | $443.07 | 2024-2025 | Evenity, Krystexxa, Prolia |
| Corcept Therapeutics | $391.19 | 2023-2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $316.34 | 2023-2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $278.53 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $251.97 | 2023-2025 | Rexulti |
| Astellas Pharma US INC | $152.67 | 2025 | Veozah |
| Glaxosmithkline, LLC. | $136.57 | 2021-2025 | Shingrix, Trelegy Ellipta, Bexsero |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.26 | 2022-2025 | Jardiance |
| Xeris Pharmaceuticals, INC. | $56.23 | 2021-2023 | Gvoke Hypopen, Keveyis |
| Bard Peripheral Vascular, INC. | $56.12 | 2025 | |
| Exact Sciences Corporation | $54.63 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $52.89 | 2021-2025 | Capvaxive, Verquvo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $52.62 | 2021-2025 | |
| Nevro Corp. | $51.41 | 2022 | |
| Amarin Pharma, INC. | $41.77 | 2021 | |
| Pfizer INC. | $37.25 | 2021 | |
| Paratek Pharmaceuticals, INC. | $27.99 | 2025 | Nuzyra |
| Ironwood Pharmaceuticals, INC | $26.54 | 2022 | |
| Biogen, INC. | $25.77 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $25.02 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.64 | 2024 | Trulance |
| Alnylam Pharmaceuticals INC. | $22.61 | 2025 | Givlaari |
| Abbvie INC. | $21.95 | 2021 | |
| Fresenius USA Marketing, INC. | $19.75 | 2021 | |
| Cequr Corporation | $19.06 | 2025 | Cequr Simplicity |
| Stryker Corporation | $18.86 | 2023 | 7 X 23mm Citrelock Implant, Citrefix, Claw II |
| Takeda Pharmaceuticals U.S.A., INC. | $18.51 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.08 | 2025 | Evkeeza |
| Medtronic, INC. | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Klockmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.